Jitendra Wadhane - Dec 23, 2024 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
SVP, Chief Accounting Officer
Signature
/s/ Jitendra Wadhane
Stock symbol
PYXS
Transactions as of
Dec 23, 2024
Transactions value $
$0
Form type
4
Date filed
12/23/2024, 04:26 PM
Previous filing
Mar 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $0 +150K $0.00 150K Dec 23, 2024 Common Stock 150K $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest in full on December 23, 2025, subject to the Reporting Person's continued employment through the vesting date.